gabapentin enacarbil horizant er ustooltip united states regnite japan anticonvulsant analgesic drug gabapentinoid class prodrug designed increased oral bioavailability human trials showed produce extended release gabapentin almost twice overall especially taken fatty gabapentin enacarbil passed human clinical trials treatment restless legs syndrome initial results shown well tolerated reasonably gabapentin enacarbil denied approval us food drug administration fda february citing concerns possible increased cancer risk shown animal studies similar concerns raised gabapentin past felt outweighed clinical utility anticonvulsant whereas treatment restless legs syndrome seen justify kind april xenoport received fda approval horizant gabapentin enacarbil treatment moderatetosevere restless legs june fda approved horizant treatment postherpetic neuralgia httpsenwikipediaorgwikigabapentinenacarbil